APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chloroquine Drug for COVID-19

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Chloroquine Drug for COVID-19 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025195 pages

Choose your research edition.

Industry ResearchChloroquine Drug for COVID-19 Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Chloroquine Drug for COVID-19 Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Chloroquine Drug for COVID-19 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chloroquine Drug for COVID-19 Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Chloroquine Drug for COVID-19 Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Chloroquine Drug for COVID-19 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Chloroquine Drug for COVID-19 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chloroquine Drug for COVID-19 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chloroquine Drug for COVID-19 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Chloroquine Drug for COVID-19 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Chloroquine Drug for COVID-19 include Zhongsheng Pharma, Sichuan Sunny Hope, Shanghai Pharma, Jinghua Pharmaceutical Group, North China Pharmaceutical Group, Guangzhou Baiyunshan Guanghua Pharmaceutical, Bayer, Sun Pharma and Rising Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Chloroquine Drug for COVID-19 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chloroquine Drug for COVID-19 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chloroquine Drug for COVID-19 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Chloroquine Drug for COVID-19 market size, projected growth trends, production technologies, key applications, and end-use industries.

Chloroquine Drug for COVID-19 Segment by Company

Zhongsheng Pharma

Sichuan Sunny Hope

Shanghai Pharma

Jinghua Pharmaceutical Group

North China Pharmaceutical Group

Guangzhou Baiyunshan Guanghua Pharmaceutical

Bayer

Sun Pharma

Rising Pharmaceutical

KPC Group

CSPC Group

Chloroquine Drug for COVID-19 Segment by Type

Tablet

Injection

Chloroquine Drug for COVID-19 Segment by Application

Mild Symptom Patient

Critically Ill Patient

Chloroquine Drug for COVID-19 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chloroquine Drug for COVID-19 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chloroquine Drug for COVID-19 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chloroquine Drug for COVID-19.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Chloroquine Drug for COVID-19 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Chloroquine Drug for COVID-19 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Chloroquine Drug for COVID-19 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Chloroquine Drug for COVID-19 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Chloroquine Drug for COVID-19 Industry Trends Table 2. Chloroquine Drug for COVID-19 Industry Drivers Table 3. Chloroquine Drug for COVID-19 Industry Opportunities and Challenges Table 4. Chloroquine Drug for COVID-19 Industry Restraints Table 5. Global Chloroquine Drug for COVID-19 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Chloroquine Drug for COVID-19 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Chloroquine Drug for COVID-19 Sales by Manufacturers (Tons) & (2021-2026) Table 8. Global Chloroquine Drug for COVID-19 Sales Market Share by Manufacturers Table 9. Global Chloroquine Drug for COVID-19 Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Chloroquine Drug for COVID-19 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Chloroquine Drug for COVID-19 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Chloroquine Drug for COVID-19 Manufacturers, Product Type & Application Table 13. Global Chloroquine Drug for COVID-19 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Chloroquine Drug for COVID-19 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablet Table 17. Major Manufacturers of Injection Table 18. Global Chloroquine Drug for COVID-19 Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 19. Global Chloroquine Drug for COVID-19 Sales by Type (2021-2026) & (Tons) Table 20. Global Chloroquine Drug for COVID-19 Sales by Type (2027-2032) & (Tons) Table 21. Global Chloroquine Drug for COVID-19 Sales Market Share by Type (2021-2026) Table 22. Global Chloroquine Drug for COVID-19 Sales Market Share by Type (2027-2032) Table 23. Global Chloroquine Drug for COVID-19 Revenue by Type 2021 VS 2025 VS 2032 (Tons) Table 24. Global Chloroquine Drug for COVID-19 Revenue by Type (2021-2026) & (Tons) Table 25. Global Chloroquine Drug for COVID-19 Revenue by Type (2027-2032) & (Tons) Table 26. Global Chloroquine Drug for COVID-19 Revenue Market Share by Type (2021-2026) Table 27. Global Chloroquine Drug for COVID-19 Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Mild Symptom Patient Table 29. Major Manufacturers of Critically Ill Patient Table 30. Global Chloroquine Drug for COVID-19 Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 31. Global Chloroquine Drug for COVID-19 Sales by Application (2021-2026) & (Tons) Table 32. Global Chloroquine Drug for COVID-19 Sales by Application (2027-2032) & (Tons) Table 33. Global Chloroquine Drug for COVID-19 Sales Market Share by Application (2021-2026) Table 34. Global Chloroquine Drug for COVID-19 Sales Market Share by Application (2027-2032) Table 35. Global Chloroquine Drug for COVID-19 Revenue by Application 2021 VS 2025 VS 2032 (Tons) Table 36. Global Chloroquine Drug for COVID-19 Revenue by Application (2021-2026) & (Tons) Table 37. Global Chloroquine Drug for COVID-19 Revenue by Application (2027-2032) & (Tons) Table 38. Global Chloroquine Drug for COVID-19 Revenue Market Share by Application (2021-2026) Table 39. Global Chloroquine Drug for COVID-19 Revenue Market Share by Application (2027-2032) Table 40. Global Chloroquine Drug for COVID-19 Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 41. Global Chloroquine Drug for COVID-19 Sales by Region (2021-2026) & (Tons) Table 42. Global Chloroquine Drug for COVID-19 Sales Market Share by Region (2021-2026) Table 43. Global Chloroquine Drug for COVID-19 Sales Forecasted by Region (2027-2032) & (Tons) Table 44. Global Chloroquine Drug for COVID-19 Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Chloroquine Drug for COVID-19 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 46. North America Chloroquine Drug for COVID-19 Sales by Country (2021-2026) & (Tons) Table 47. North America Chloroquine Drug for COVID-19 Sales by Country (2027-2032) & (Tons) Table 48. Europe Chloroquine Drug for COVID-19 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 49. Europe Chloroquine Drug for COVID-19 Sales by Country (2021-2026) & (Tons) Table 50. Europe Chloroquine Drug for COVID-19 Sales by Country (2027-2032) & (Tons) Table 51. Asia Pacific Chloroquine Drug for COVID-19 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 52. Asia Pacific Chloroquine Drug for COVID-19 Sales by Country (2021-2026) & (Tons) Table 53. Asia Pacific Chloroquine Drug for COVID-19 Sales by Country (2027-2032) & (Tons) Table 54. South America, Middle East and Africa Chloroquine Drug for COVID-19 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 55. South America, Middle East and Africa Chloroquine Drug for COVID-19 Sales by Country (2021-2026) & (Tons) Table 56. South America, Middle East and Africa Chloroquine Drug for COVID-19 Sales by Country (2027-2032) & (Tons) Table 57. Global Chloroquine Drug for COVID-19 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Chloroquine Drug for COVID-19 Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Chloroquine Drug for COVID-19 Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Chloroquine Drug for COVID-19 Revenue Market Share by Region (2021-2026) Table 61. Global Chloroquine Drug for COVID-19 Revenue Market Share by Region (2027-2032) Table 62. Zhongsheng Pharma Company Information Table 63. Zhongsheng Pharma Business Overview Table 64. Zhongsheng Pharma Chloroquine Drug for COVID-19 Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Zhongsheng Pharma Chloroquine Drug for COVID-19 Product Portfolio Table 66. Zhongsheng Pharma Recent Development Table 67. Sichuan Sunny Hope Company Information Table 68. Sichuan Sunny Hope Business Overview Table 69. Sichuan Sunny Hope Chloroquine Drug for COVID-19 Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Sichuan Sunny Hope Chloroquine Drug for COVID-19 Product Portfolio Table 71. Sichuan Sunny Hope Recent Development Table 72. Shanghai Pharma Company Information Table 73. Shanghai Pharma Business Overview Table 74. Shanghai Pharma Chloroquine Drug for COVID-19 Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Shanghai Pharma Chloroquine Drug for COVID-19 Product Portfolio Table 76. Shanghai Pharma Recent Development Table 77. Jinghua Pharmaceutical Group Company Information Table 78. Jinghua Pharmaceutical Group Business Overview Table 79. Jinghua Pharmaceutical Group Chloroquine Drug for COVID-19 Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Jinghua Pharmaceutical Group Chloroquine Drug for COVID-19 Product Portfolio Table 81. Jinghua Pharmaceutical Group Recent Development Table 82. North China Pharmaceutical Group Company Information Table 83. North China Pharmaceutical Group Business Overview Table 84. North China Pharmaceutical Group Chloroquine Drug for COVID-19 Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. North China Pharmaceutical Group Chloroquine Drug for COVID-19 Product Portfolio Table 86. North China Pharmaceutical Group Recent Development Table 87. Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information Table 88. Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview Table 89. Guangzhou Baiyunshan Guanghua Pharmaceutical Chloroquine Drug for COVID-19 Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Guangzhou Baiyunshan Guanghua Pharmaceutical Chloroquine Drug for COVID-19 Product Portfolio Table 91. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development Table 92. Bayer Company Information Table 93. Bayer Business Overview Table 94. Bayer Chloroquine Drug for COVID-19 Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Bayer Chloroquine Drug for COVID-19 Product Portfolio Table 96. Bayer Recent Development Table 97. Sun Pharma Company Information Table 98. Sun Pharma Business Overview Table 99. Sun Pharma Chloroquine Drug for COVID-19 Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Sun Pharma Chloroquine Drug for COVID-19 Product Portfolio Table 101. Sun Pharma Recent Development Table 102. Rising Pharmaceutical Company Information Table 103. Rising Pharmaceutical Business Overview Table 104. Rising Pharmaceutical Chloroquine Drug for COVID-19 Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Rising Pharmaceutical Chloroquine Drug for COVID-19 Product Portfolio Table 106. Rising Pharmaceutical Recent Development Table 107. KPC Group Company Information Table 108. KPC Group Business Overview Table 109. KPC Group Chloroquine Drug for COVID-19 Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. KPC Group Chloroquine Drug for COVID-19 Product Portfolio Table 111. KPC Group Recent Development Table 112. CSPC Group Company Information Table 113. CSPC Group Business Overview Table 114. CSPC Group Chloroquine Drug for COVID-19 Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. CSPC Group Chloroquine Drug for COVID-19 Product Portfolio Table 116. CSPC Group Recent Development Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Chloroquine Drug for COVID-19 Distributors List Table 120. Chloroquine Drug for COVID-19 Customers List Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Chloroquine Drug for COVID-19 Product Image Figure 2. Global Chloroquine Drug for COVID-19 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chloroquine Drug for COVID-19 Market Size (2021-2032) & (US$ Million) Figure 4. Global Chloroquine Drug for COVID-19 Sales (2021-2032) & (Tons) Figure 5. Global Chloroquine Drug for COVID-19 Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Chloroquine Drug for COVID-19 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablet Image Figure 9. Injection Image Figure 10. Global Chloroquine Drug for COVID-19 Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 11. Global Chloroquine Drug for COVID-19 Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Chloroquine Drug for COVID-19 Sales Market Share by Type (2021-2032) Figure 13. Global Chloroquine Drug for COVID-19 Revenue by Type (2021 VS 2025 VS 2032) & (Tons) Figure 14. Global Chloroquine Drug for COVID-19 Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Chloroquine Drug for COVID-19 Revenue Market Share by Type (2021-2032) Figure 16. Mild Symptom Patient Image Figure 17. Critically Ill Patient Image Figure 18. Global Chloroquine Drug for COVID-19 Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 19. Global Chloroquine Drug for COVID-19 Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Chloroquine Drug for COVID-19 Sales Market Share by Application (2021-2032) Figure 21. Global Chloroquine Drug for COVID-19 Revenue by Application (2021 VS 2025 VS 2032) & (Tons) Figure 22. Global Chloroquine Drug for COVID-19 Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Chloroquine Drug for COVID-19 Revenue Market Share by Application (2021-2032) Figure 24. North America Chloroquine Drug for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 25. North America Chloroquine Drug for COVID-19 Sales Market Share by Country (2021-2032) Figure 26. U.S. Chloroquine Drug for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 27. Canada Chloroquine Drug for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 28. Mexico Chloroquine Drug for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 29. Europe Chloroquine Drug for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 30. Europe Chloroquine Drug for COVID-19 Sales Market Share by Country (2021-2032) Figure 31. Germany Chloroquine Drug for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 32. France Chloroquine Drug for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 33. U.K. Chloroquine Drug for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 34. Italy Chloroquine Drug for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 35. Netherlands Chloroquine Drug for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 36. Asia Pacific Chloroquine Drug for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 37. Asia Pacific Chloroquine Drug for COVID-19 Sales Market Share by Country (2021-2032) Figure 38. China Chloroquine Drug for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 39. Japan Chloroquine Drug for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 40. South Korea Chloroquine Drug for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 41. Southeast Asia Chloroquine Drug for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 42. India Chloroquine Drug for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 43. Australia Chloroquine Drug for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 44. South America, Middle East and Africa Chloroquine Drug for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 45. South America, Middle East and Africa Chloroquine Drug for COVID-19 Sales Market Share by Country (2021-2032) Figure 46. Brazil Chloroquine Drug for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 47. South Africa Chloroquine Drug for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 48. Saudi Arabia Chloroquine Drug for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 49. Turkey Chloroquine Drug for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 50. Argentina Chloroquine Drug for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 51. UAE Chloroquine Drug for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 52. Egypt Chloroquine Drug for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 53. Chile Chloroquine Drug for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 54. Global Chloroquine Drug for COVID-19 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Chloroquine Drug for COVID-19 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Chloroquine Drug for COVID-19 Revenue (2021-2032) & (US$ Million) Figure 57. North America Chloroquine Drug for COVID-19 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Chloroquine Drug for COVID-19 Revenue (2021-2032) & (US$ Million) Figure 59. Europe Chloroquine Drug for COVID-19 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Chloroquine Drug for COVID-19 Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Chloroquine Drug for COVID-19 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Chloroquine Drug for COVID-19 Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Chloroquine Drug for COVID-19 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Chloroquine Drug for COVID-19 Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Chloroquine Drug for COVID-19 Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Injection
Applications
  • Mild Symptom Patient
  • Critically Ill Patient
Companies covered
  • Zhongsheng Pharma
  • Sichuan Sunny Hope
  • Shanghai Pharma
  • Jinghua Pharmaceutical Group
  • North China Pharmaceutical Group
  • Guangzhou Baiyunshan Guanghua Pharmaceutical
  • Bayer
  • Sun Pharma
  • Rising Pharmaceutical
  • KPC Group
  • CSPC Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Chloroquine Drug for COVID-19 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Chloroquine Drug for COVID-19 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Chloroquine Drug for COVID-19 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Chloroquine Drug for COVID-19 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Chloroquine Drug for COVID-19 Market Dynamics
  1. 2.1 Chloroquine Drug for COVID-19 Industry Trends
  2. 2.2 Chloroquine Drug for COVID-19 Industry Drivers
  3. 2.3 Chloroquine Drug for COVID-19 Industry Opportunities and Challenges
  4. 2.4 Chloroquine Drug for COVID-19 Industry Restraints
3 Chloroquine Drug for COVID-19 Market by Manufacturers
  1. 3.1 Global Chloroquine Drug for COVID-19 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Chloroquine Drug for COVID-19 Sales by Manufacturers (2021-2026)
  3. 3.3 Global Chloroquine Drug for COVID-19 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Chloroquine Drug for COVID-19 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Chloroquine Drug for COVID-19 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Chloroquine Drug for COVID-19 Manufacturers, Product Type & Application
  7. 3.7 Global Chloroquine Drug for COVID-19 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Chloroquine Drug for COVID-19 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Chloroquine Drug for COVID-19 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Chloroquine Drug for COVID-19 Tier 1, Tier 2, and Tier 3
4 Chloroquine Drug for COVID-19 Market by Type
  1. 4.1 Chloroquine Drug for COVID-19 Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Injection
  4. 4.2 Global Chloroquine Drug for COVID-19 Sales by Type
  5. 4.2.1 Global Chloroquine Drug for COVID-19 Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Chloroquine Drug for COVID-19 Sales by Type (2021-2032)
  7. 4.2.3 Global Chloroquine Drug for COVID-19 Sales Market Share by Type (2021-2032)
  8. 4.3 Global Chloroquine Drug for COVID-19 Revenue by Type
  9. 4.3.1 Global Chloroquine Drug for COVID-19 Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Chloroquine Drug for COVID-19 Revenue by Type (2021-2032)
  11. 4.3.3 Global Chloroquine Drug for COVID-19 Revenue Market Share by Type (2021-2032)
5 Chloroquine Drug for COVID-19 Market by Application
  1. 5.1 Chloroquine Drug for COVID-19 Application Introduction
  2. 5.1.1 Mild Symptom Patient
  3. 5.1.2 Critically Ill Patient
  4. 5.2 Global Chloroquine Drug for COVID-19 Sales by Application
  5. 5.2.1 Global Chloroquine Drug for COVID-19 Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Chloroquine Drug for COVID-19 Sales by Application (2021-2032)
  7. 5.2.3 Global Chloroquine Drug for COVID-19 Sales Market Share by Application (2021-2032)
  8. 5.3 Global Chloroquine Drug for COVID-19 Revenue by Application
  9. 5.3.1 Global Chloroquine Drug for COVID-19 Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Chloroquine Drug for COVID-19 Revenue by Application (2021-2032)
  11. 5.3.3 Global Chloroquine Drug for COVID-19 Revenue Market Share by Application (2021-2032)
6 Global Chloroquine Drug for COVID-19 Sales by Region
  1. 6.1 Global Chloroquine Drug for COVID-19 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chloroquine Drug for COVID-19 Sales by Region (2021-2032)
  3. 6.2.1 Global Chloroquine Drug for COVID-19 Sales by Region (2021-2026)
  4. 6.2.2 Global Chloroquine Drug for COVID-19 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Chloroquine Drug for COVID-19 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Chloroquine Drug for COVID-19 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Chloroquine Drug for COVID-19 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Chloroquine Drug for COVID-19 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Chloroquine Drug for COVID-19 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Chloroquine Drug for COVID-19 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Chloroquine Drug for COVID-19 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Chloroquine Drug for COVID-19 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Chloroquine Drug for COVID-19 Revenue by Region
  1. 7.1 Global Chloroquine Drug for COVID-19 Revenue by Region
  2. 7.1.1 Global Chloroquine Drug for COVID-19 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Chloroquine Drug for COVID-19 Revenue by Region (2021-2026)
  4. 7.1.3 Global Chloroquine Drug for COVID-19 Revenue by Region (2027-2032)
  5. 7.1.4 Global Chloroquine Drug for COVID-19 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Chloroquine Drug for COVID-19 Revenue (2021-2032)
  8. 7.2.2 North America Chloroquine Drug for COVID-19 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Chloroquine Drug for COVID-19 Revenue (2021-2032)
  11. 7.3.2 Europe Chloroquine Drug for COVID-19 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Chloroquine Drug for COVID-19 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Chloroquine Drug for COVID-19 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Chloroquine Drug for COVID-19 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Chloroquine Drug for COVID-19 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhongsheng Pharma
  2. 8.1.1 Zhongsheng Pharma Company Information
  3. 8.1.2 Zhongsheng Pharma Business Overview
  4. 8.1.3 Zhongsheng Pharma Chloroquine Drug for COVID-19 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhongsheng Pharma Chloroquine Drug for COVID-19 Product Portfolio
  6. 8.1.5 Zhongsheng Pharma Recent Developments
  7. 8.2 Sichuan Sunny Hope
  8. 8.2.1 Sichuan Sunny Hope Company Information
  9. 8.2.2 Sichuan Sunny Hope Business Overview
  10. 8.2.3 Sichuan Sunny Hope Chloroquine Drug for COVID-19 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sichuan Sunny Hope Chloroquine Drug for COVID-19 Product Portfolio
  12. 8.2.5 Sichuan Sunny Hope Recent Developments
  13. 8.3 Shanghai Pharma
  14. 8.3.1 Shanghai Pharma Company Information
  15. 8.3.2 Shanghai Pharma Business Overview
  16. 8.3.3 Shanghai Pharma Chloroquine Drug for COVID-19 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai Pharma Chloroquine Drug for COVID-19 Product Portfolio
  18. 8.3.5 Shanghai Pharma Recent Developments
  19. 8.4 Jinghua Pharmaceutical Group
  20. 8.4.1 Jinghua Pharmaceutical Group Company Information
  21. 8.4.2 Jinghua Pharmaceutical Group Business Overview
  22. 8.4.3 Jinghua Pharmaceutical Group Chloroquine Drug for COVID-19 Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Jinghua Pharmaceutical Group Chloroquine Drug for COVID-19 Product Portfolio
  24. 8.4.5 Jinghua Pharmaceutical Group Recent Developments
  25. 8.5 North China Pharmaceutical Group
  26. 8.5.1 North China Pharmaceutical Group Company Information
  27. 8.5.2 North China Pharmaceutical Group Business Overview
  28. 8.5.3 North China Pharmaceutical Group Chloroquine Drug for COVID-19 Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 North China Pharmaceutical Group Chloroquine Drug for COVID-19 Product Portfolio
  30. 8.5.5 North China Pharmaceutical Group Recent Developments
  31. 8.6 Guangzhou Baiyunshan Guanghua Pharmaceutical
  32. 8.6.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information
  33. 8.6.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview
  34. 8.6.3 Guangzhou Baiyunshan Guanghua Pharmaceutical Chloroquine Drug for COVID-19 Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Chloroquine Drug for COVID-19 Product Portfolio
  36. 8.6.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments
  37. 8.7 Bayer
  38. 8.7.1 Bayer Company Information
  39. 8.7.2 Bayer Business Overview
  40. 8.7.3 Bayer Chloroquine Drug for COVID-19 Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bayer Chloroquine Drug for COVID-19 Product Portfolio
  42. 8.7.5 Bayer Recent Developments
  43. 8.8 Sun Pharma
  44. 8.8.1 Sun Pharma Company Information
  45. 8.8.2 Sun Pharma Business Overview
  46. 8.8.3 Sun Pharma Chloroquine Drug for COVID-19 Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sun Pharma Chloroquine Drug for COVID-19 Product Portfolio
  48. 8.8.5 Sun Pharma Recent Developments
  49. 8.9 Rising Pharmaceutical
  50. 8.9.1 Rising Pharmaceutical Company Information
  51. 8.9.2 Rising Pharmaceutical Business Overview
  52. 8.9.3 Rising Pharmaceutical Chloroquine Drug for COVID-19 Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Rising Pharmaceutical Chloroquine Drug for COVID-19 Product Portfolio
  54. 8.9.5 Rising Pharmaceutical Recent Developments
  55. 8.10 KPC Group
  56. 8.10.1 KPC Group Company Information
  57. 8.10.2 KPC Group Business Overview
  58. 8.10.3 KPC Group Chloroquine Drug for COVID-19 Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 KPC Group Chloroquine Drug for COVID-19 Product Portfolio
  60. 8.10.5 KPC Group Recent Developments
  61. 8.11 CSPC Group
  62. 8.11.1 CSPC Group Company Information
  63. 8.11.2 CSPC Group Business Overview
  64. 8.11.3 CSPC Group Chloroquine Drug for COVID-19 Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 CSPC Group Chloroquine Drug for COVID-19 Product Portfolio
  66. 8.11.5 CSPC Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Chloroquine Drug for COVID-19 Value Chain Analysis
  2. 9.1.1 Chloroquine Drug for COVID-19 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Chloroquine Drug for COVID-19 Production Mode & Process
  6. 9.2 Chloroquine Drug for COVID-19 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Chloroquine Drug for COVID-19 Distributors
  9. 9.2.3 Chloroquine Drug for COVID-19 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst